A test has been created in Russia to determine the effectiveness of antibodies to coronavirus

Scientists from the Institute of Bioorganic Chemistry named after Academicians M.M. Shemyakin and Yu.A. Ovchinnikov invented the test,

determining the effectiveness of antibodies to coronavirus. In Russia, such a test was created and tested in clinical trials for the first time. Discuss

Routine tests check the amount of antibodies andthe estimated strength of the immune response. The new test allows you to determine the "quality" of antibodies - how successfully neutralizing antibodies prevent the virus from binding to the receptor, penetrating into the cell and multiplying there.

According to virologist Georgy Scriabin, thisthe test was developed on the basis of blood serum samples from patients and a conventional enzyme-linked immunosorbent assay for antibodies. The prototypes were transferred to the Central Clinical Hospital of the Russian Academy of Sciences for testing: it is important to understand not only the number of antibodies, but how they will actually manifest themselves - with an equal number of antibodies in different people, they can be more or less effective.

As noted, the most active to coronavirusantibodies were in people who had been ill about a year ago, and then were vaccinated, and in those who had recently been ill. Some of the sera of people who had been ill had rather "weak" antibodies.

Another expert, managerClinical diagnostic laboratory of the Central Clinical Hospital of the Russian Academy of Sciences Natalya Aleshenko said that knowledge of the activity of antibodies will help to understand whether a person should be vaccinated (revaccinated) or not.

In the near future, the test will be submitted to Roszdravnadzor for registration.

Source: Izvestia